Literature DB >> 26686372

Effect of a cardiac rehabilitation program on exercise oscillatory ventilation in Japanese patients with heart failure.

Fumitake Yamauchi1,2, Hitoshi Adachi1, Jun-Ichi Tomono1, Shigeru Toyoda3, Koichi Iwamatsu1, Masashi Sakuma2, Toshiaki Nakajima2,4, Shigeru Oshima1, Teruo Inoue2.   

Abstract

Although exercise oscillatory ventilation has emerged as a potent independent risk factor for adverse prognosis in heart failure, it is not well known whether cardiac rehabilitation can improve oscillatory ventilation. In this study, we investigated the magnitude of oscillations in ventilation before and after cardiac rehabilitation in chronic heart failure patients with exercise oscillatory ventilation. Cardiac rehabilitation (5-month program) was performed in 26 patients with chronic heart failure who showed an oscillatory ventilation pattern during cardiopulmonary exercise testing (CPX). After the 5-month rehabilitation program was completed, the patients again underwent CPX. To determine the magnitude of oscillations in ventilation, the amplitude and cycle length of the oscillations were calculated and compared with several other parameters, including biomarkers that have established prognostic value in heart failure. At baseline before cardiac rehabilitation, both oscillation amplitude (R = 0.625, P < 0.01) and cycle length (R = 0.469, P < 0.05) were positively correlated with the slope of minute ventilation vs. carbon dioxide production. Plasma BNP levels were positively correlated with amplitude (R = 0.615, P < 0.01) but not cycle length (R = 0.371). Cardiac rehabilitation decreased oscillation amplitude (P < 0.01) but failed to change cycle length. The change in amplitude was positively correlated with the change in BNP levels (R = 0.760, P < 0.01). Multiple regression analysis showed that only the change in amplitude was an independent predictor of the change in BNP levels (R = 0.717, P < 0.01). A 5-month cardiac rehabilitation program improves exercise oscillatory ventilation in chronic heart failure patients by reducing the oscillation amplitude. This effect is associated with a reduction of plasma BNP levels, potentially contributing to an improvement of heart failure.

Entities:  

Keywords:  Brain natriuretic peptide; Cardiopulmonary exercise testing; Chronic heart failure; Exercise oscillatory ventilation; Oscillation amplitude

Mesh:

Substances:

Year:  2015        PMID: 26686372     DOI: 10.1007/s00380-015-0782-x

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  32 in total

1.  Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison.

Authors:  Ross Arena; Jonathan Myers; Syed Salman Aslam; Elsa B Varughese; Mary Ann Peberdy
Journal:  Am Heart J       Date:  2004-02       Impact factor: 4.749

2.  Oscillatory breathing patterns during wakefulness in patients with chronic heart failure: clinical implications and role of augmented peripheral chemosensitivity.

Authors:  P Ponikowski; S D Anker; T P Chua; D Francis; W Banasiak; P A Poole-Wilson; A J Coats; M Piepoli
Journal:  Circulation       Date:  1999-12-14       Impact factor: 29.690

3.  A mechanism of central sleep apnea in patients with heart failure.

Authors:  S Javaheri
Journal:  N Engl J Med       Date:  1999-09-23       Impact factor: 91.245

4.  Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence.

Authors:  Ugo Corrà; Massimo Pistono; Alessandro Mezzani; Alberto Braghiroli; Andrea Giordano; Paola Lanfranchi; Enzo Bosimini; Marco Gnemmi; Pantaleo Giannuzzi
Journal:  Circulation       Date:  2005-12-27       Impact factor: 29.690

5.  Oscillatory breathing and exercise gas exchange abnormalities prognosticate early mortality and morbidity in heart failure.

Authors:  Xing-Guo Sun; James E Hansen; John F Beshai; Karlman Wasserman
Journal:  J Am Coll Cardiol       Date:  2010-04-27       Impact factor: 24.094

6.  Prognostic value of timing and duration characteristics of exercise oscillatory ventilation in patients with heart failure.

Authors:  Ross Arena; Jonathan Myers; Joshua Abella; Mary Ann Peberdy; Sherry Pinkstaff; Daniel Bensimhon; Paul Chase; Marco Guazzi
Journal:  J Heart Lung Transplant       Date:  2008-03       Impact factor: 10.247

7.  Optimizing the exercise protocol for cardiopulmonary assessment.

Authors:  M J Buchfuhrer; J E Hansen; T E Robinson; D Y Sue; K Wasserman; B J Whipp
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-11

8.  Clinical value of B-type natriuretic peptide for the assessment of left ventricular filling pressures in patients with systolic heart failure and inconclusive tissue Doppler indexes.

Authors:  Apostolos Karavidas; George Lazaros; Evangelos Matsakas; Dimitrios Farmakis; John Parissis; Ioannis A Paraskevaidis; Christos Michailidis; Dimitrios Avramidis; Achilleas Zacharoulis; Sophia Arapi; Andreas Kaoukis; Apostolos Zacharoulis
Journal:  Heart Vessels       Date:  2008-05-17       Impact factor: 2.037

9.  Periodic breathing during incremental exercise predicts mortality in patients with chronic heart failure evaluated for cardiac transplantation.

Authors:  Joao J Leite; Alfredo J Mansur; Humberto F G de Freitas; Paulo R Chizola; Edimar A Bocchi; Mario Terra-Filho; J Alberto Neder; Geraldo Lorenzi-Filho
Journal:  J Am Coll Cardiol       Date:  2003-06-18       Impact factor: 24.094

10.  Stimulation of pulmonary vagal afferent C-fibers by lung edema in dogs.

Authors:  A M Roberts; J Bhattacharya; H D Schultz; H M Coleridge; J C Coleridge
Journal:  Circ Res       Date:  1986-04       Impact factor: 17.367

View more
  1 in total

1.  Internet-based training of coronary artery patients: the Heart Cycle Trial.

Authors:  Erik Skobel; Christian Knackstedt; Alvaro Martinez-Romero; Dario Salvi; Cecilia Vera-Munoz; Andreas Napp; Jean Luprano; Ramon Bover; Sigrid Glöggler; Birna Bjarnason-Wehrens; Nikolaus Marx; Alan Rigby; John Cleland
Journal:  Heart Vessels       Date:  2016-10-11       Impact factor: 2.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.